Mycoplasma pneumoniae is an atypical pathogen. It is neither a virus nor a bacterium, but a microorganism intermediate in size between a bacterium and a virus.

Mycoplasma pneumoniae, a microorganism that is distinct from bacteria, its size is between bacteria and viruses, and it arouses mycoplasma pneumoniae infection when it enters the human body.

The clinical application of the colloidal gold method rapid detection program for mycoplasma pneumonia infections holds significant importance in the field of healthcare.

Respiratory infections are a significant global health concern, affecting millions of individuals each year. Among the various pathogens responsible for respiratory infections, Mycoplasma pneumoniae, a bacterium commonly known as "atypical pneumonia," and has gained attention due to its increasing prevalence and potential complications.

Recently, another infectious disease, mycoplasma pneumonia, has also entered a high incidence period.

Pneumonia is a common respiratory disease that can be caused by a variety of pathogens. Among them, Mycoplasma pneumoniae and Chlamydia pneumoniae are important pathogens that cause atypical pneumonia. The detection of these two pathogens has become increasingly important in the clinical diagnosis and treatment of pneumonia.

Seven products (HP-Ab, HP-Ag, Mpn-IgM, EV-71, RV/AV, RV, MEV) produced by Wiz Biotech were approved by CFDA.